NASDAQ:FEMY

Femasys Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy FEMY

*Your capital is at risk

$4.01

-0.0700 (-1.72%)

At Close: Jun 23, 2026

Femasys Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 5.58M and sold 0 FEMY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	5.58M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 30, 2026 Buy	Common Stock	Canning John Charles Chief Operating Officer	C-Suite Officer	0 Value: $0
Mar 30, 2026 Buy	Stock Option (Right to Buy) A-Award	Canning John Charles Chief Operating Officer	C-Suite Officer	150 000 Value: $57.0K
Mar 19, 2026 Buy	Series D-1 Warrants A-Award	Larsen Charles Director	Director	34 122 Value: $19.8K
Mar 19, 2026 Buy	Series D-1 Warrants A-Award	Eichenbaum Kenneth D. Director	Director	102 366 Value: $59.4K
Mar 19, 2026 Buy	Series D-1 Warrants A-Award	Elefant Dov Chief Financial Officer	C-Suite Officer	34 122 Value: $19.8K
Mar 19, 2026 Buy	Series D-1 Warrants A-Award	Lee-sepsick Kathy Chief Executive Officer	CEO / President	68 244 Value: $39.6K
Mar 18, 2026 Buy	Common Stock	Eichenbaum Kenneth D. Director	Director	0 Value: $0
Mar 18, 2026 Buy	Stock Option (Right to Buy) A-Award	Eichenbaum Kenneth D. Director	Director	35 200 Value: $21.1K
Mar 17, 2026 Buy	Common Stock J-Other	Silverman Joshua	Director	0 Value: $0
Mar 17, 2026 Buy	Common Stock J-Other	Pharmacyte Biotech, Inc.	10% Owner	0 Value: $0
Feb 19, 2026 Buy	Restricted Stock Units A-Award	Elefant Dov Chief Financial Officer	C-Suite Officer	169 000 Value: $1.85M
Feb 19, 2026 Buy	Restricted Stock Units A-Award	Elefant Dov Chief Financial Officer	C-Suite Officer	173 000 Value: $1.89M
Feb 19, 2026 Buy	Restricted Stock Units A-Award	Lee-sepsick Kathy Chief Executive Officer	CEO / President	282 000 Value: $3.08M
Feb 19, 2026 Buy	Restricted Stock Units A-Award	Lee-sepsick Kathy Chief Executive Officer	CEO / President	447 000 Value: $4.88M
Feb 02, 2026 Buy	Restricted Stock Units A-Award	Sipos Jeremy Alexander Chief Technology Officer	Officer	80 000 Value: $825.6K
Dec 16, 2025 Buy	Employee Stock Option (Right to Buy)	Sipos Jeremy Alexander Chief Technology Officer	Officer	34 700 Value: $36.4K
Dec 16, 2025 Buy	Employee Stock Option (Right to Buy)	Sipos Jeremy Alexander Chief Technology Officer	Officer	34 700 Value: $27.8K
Dec 16, 2025 Buy	Employee Stock Option (Right to Buy)	Sipos Jeremy Alexander Chief Technology Officer	Officer	14 800 Value: $12.9K
Dec 16, 2025 Buy	Employee Stock Option (Right to Buy)	Sipos Jeremy Alexander Chief Technology Officer	Officer	14 800 Value: $44.4K
Dec 16, 2025 Buy	Employee Stock Option (Right to Buy)	Sipos Jeremy Alexander Chief Technology Officer	Officer	3 334 Value: $20.4K
Dec 16, 2025 Buy	Employee Stock Option (Right to Buy)	Sipos Jeremy Alexander Chief Technology Officer	Officer	27 778 Value: $90.0K
Dec 16, 2025 Buy	Common Stock	Sipos Jeremy Alexander Chief Technology Officer	Officer	0 Value: $0
Nov 07, 2025 Buy	Series B-1 Warrants	Eichenbaum Kenneth D. Director	Director	102 366 Value: $94.2K
Nov 07, 2025 Buy	Series C-1 Warrants	Eichenbaum Kenneth D. Director	Director	102 366 Value: $112.6K
Nov 07, 2025 Buy	Senior Secured Convertible Notes	Eichenbaum Kenneth D. Director	Director	102 366 Value: $74.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT FEMASYS INC.

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United Sta...

Read Full Profile Here